Letter to the Editor: Murphy C, Byrne S, Ahmed G, Kenny A, Gallagher J, Harvey H, O’Farrell, Bird B. Cost Implication of Reactive Versus Prospective Testing for DPD Deficiency in Patients with Colorectal Cancer: A Single Institution Experience. . 2018; 16(4)

• Michael Bamat

Affiliations

Michael Bamat

Wellstat Therapeutics Corporation, Gaithersburg, MD, USA